Gene · 23607
Papers1,907
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,907
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Disulfidptosis-related signature elucidates the prognostic, immunologic, and therapeutic characteristics in ovarian cancer. | Front Genet | 2024 | 38694875 | PubTator, text mining | PubMed |
| CD2AP is a potential prognostic biomarker of renal clear cell carcinoma. | Cancer Med | 2024 | 38457255 | PubTator, text mining | PubMed |
| Systemic proteome adaptions to 7-day complete caloric restriction in humans. | Nat Metab | 2024 | 38429390 | PubTator, text mining | PubMed |
| Noncanonical function of folate through folate receptor 1 during neural tube formation. | Nat Commun | 2024 | 38388461 | PubTator, text mining | PubMed |
| Hepatitis B virus-targeting sodium taurocholate cotransporting polypeptide mediates HBV infection and damage in human renal podocytes. | Microbiol Spectr | 2024 | 38315030 | PubTator, text mining | PubMed |
| circCD2AP promotes epithelial mesenchymal transition and stemness in bladder cancer by regulating FOXQ1/USP21 axis. | iScience | 2024 | 38292422 | PubTator, text mining | PubMed |
| Knowledge domains and emerging trends of Genome-wide association studies in Alzheimer's disease: A bibliometric analysis and visualization study from 2002 to 2022. | PLoS One | 2024 | 38241287 | PubTator, text mining | PubMed |
| Cytoskeleton Rearrangement in Podocytopathies: An Update. | Int J Mol Sci | 2024 | 38203817 | PubTator, text mining | PubMed |
| Identification of prognostic risk score of disulfidptosis-related genes and molecular subtypes in glioma. | Biochem Biophys Rep | 2024 | 38188362 | PubTator, text mining | PubMed |
| Measurement of urinary exosomal phospholipase A2 receptor is a sensitive method for diagnosis of PLA2R-associated membranous nephropathy. | Clin Kidney J | 2024 | 38186888 | PubTator, text mining | PubMed |
| A novel disulfidptosis-related lncRNAs signature for predicting survival and immune response in hepatocellular carcinoma. | Aging (Albany NY) | 2024 | 38180745 | PubTator, text mining | PubMed |
| The HLA-DRB1*09:01-DQB1*03:03 haplotype is associated with the risk for late-onset Alzheimer's disease in APOE ε 4-negative Japanese adults. | NPJ Aging | 2024 | 38167405 | PubTator, text mining | PubMed |
| Role of the Ste20-like kinase SLK in podocyte adhesion. | Physiol Rep | 2024 | 38163671 | PubTator, text mining | PubMed |
| The Alzheimer's Disease Neuroimaging Initiative in the era of Alzheimer's disease treatment: A review of ADNI studies from 2021 to 2022. | Alzheimers Dement | 2024 | 37698424 | PubTator, text mining | PubMed |
| Ocular manifestations of the genetic causes of focal and segmental glomerulosclerosis. | Pediatr Nephrol | 2024 | 37578539 | PubTator, text mining | PubMed |
| Understanding the podocyte immune responses in proteinuric kidney diseases: from pathogenesis to therapy. | Front Immunol | 2023 | 38288116 | PubTator, text mining | PubMed |
| There Are No Insurmountable Barriers: Passage of the Helicobacter pylori VacA Toxin from Bacterial Cytoplasm to Eukaryotic Cell Organelle. | Membranes (Basel) | 2023 | 38248700 | PubTator, text mining | PubMed |
| Integrative analysis of disulfidptosis and immune microenvironment in hepatocellular carcinoma: a putative model and immunotherapeutic strategies. | Front Immunol | 2023 | 38235128 | PubTator, text mining | PubMed |
| Collapsing Glomerulopathy in a Patient with a TRPC6 Mutation Presenting as Rapidly Progressive Glomerulonephritis: A Case Report and Review of the Literature. | Saudi J Kidney Dis Transpl | 2023 | 38231721 | PubTator, text mining | PubMed |
| Top Alzheimer's disease risk allele frequencies differ in HABS-HD Mexican- versus Non-Hispanic White Americans. | Alzheimers Dement (Amst) | 2023 | 38155914 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23607/papers?page=5